Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrille Hoarau

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
Devastating Gynecological Infections in Women with STAT3 DeficiencyAlexis Redor, François Danion, Perrine Parize, et al.
Journal of Clinical Immunology|June 2, 2018
Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency PatientsBoris Bienvenu, Grégoire Cozon, Yves Mataix, et al.
Circulation. Cardiovascular Genetics|November 16, 2011
Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiencyMarie-Olivia Chandesris, Arshid Azarine, Kim-Thanh Ong, et al.
Blood|September 25, 2012
IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patientsSandra Weller, Mélanie Bonnet, Héloïse Delagreverie, et al.
Allergy and Asthma Proceedings|July 22, 2022
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needsLaurence Bouillet, Olivier Fain, Guillaume Armengol, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Medicine|July 4, 2012
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyMarie-Olivia Chandesris, Isabelle Melki, Angels Natividad, et al.
The Journal of Experimental Medicine|July 2, 2008
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cellsLudovic de Beaucoudrey, Anne Puel, Orchidée Filipe-Santos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
Devastating Gynecological Infections in Women with STAT3 DeficiencyAlexis Redor, François Danion, Perrine Parize, et al.
Journal of Clinical Immunology|June 2, 2018
Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency PatientsBoris Bienvenu, Grégoire Cozon, Yves Mataix, et al.
Circulation. Cardiovascular Genetics|November 16, 2011
Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiencyMarie-Olivia Chandesris, Arshid Azarine, Kim-Thanh Ong, et al.
Blood|September 25, 2012
IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patientsSandra Weller, Mélanie Bonnet, Héloïse Delagreverie, et al.
Allergy and Asthma Proceedings|July 22, 2022
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needsLaurence Bouillet, Olivier Fain, Guillaume Armengol, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Medicine|July 4, 2012
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyMarie-Olivia Chandesris, Isabelle Melki, Angels Natividad, et al.
The Journal of Experimental Medicine|July 2, 2008
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cellsLudovic de Beaucoudrey, Anne Puel, Orchidée Filipe-Santos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
Pageof 4